QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

COO

QT65The Cooper Companies, Inc.
NASDAQ·Healthcare·Medical - Instruments & Supplies·USA
Latest market price
65.91
+0.86+1.32%
OverviewShort InterestFilings
COOQT65The Cooper Companies, Inc.·NASDAQ
OverviewShort InterestFilings
65.91+1.32%
TA
Loading chart...
Screen all →
BDX+1.67%$143.98ALC+0.84%$64.68MDLN-1.32%$35.94WST+1.35%$327.95BAX+2.58%$19.89ATR+0.28%$120.32RGEN-1.15%$132.02AVTR+1.27%$9.58
Snapshot
Index-P/E53.79EPS (ttm)1.18
Insider Own0.61%
Shs Outstand195.03M
Perf Week-2.37%
Market Cap12.69BForward P/E13.14EPS next Y5.02Insider Trans0.09%Shs Float-Perf Month7.26%
Enterprise Value15.01BPEG-EPS next Q1.13Inst Own-Short Float-Perf Quarter-6.79%
Income235.97MP/S3.00EPS this Y292.17%Inst Trans-Short Ratio-Perf Half Y-18.67%
Sales4.23BP/B1.54EPS next Y8.37%ROA1.89%Short Interest-Perf YTD-19.58%
Book/sh42.24P/C13.31EPS next 5Y8.64%ROE2.84%52W High89.83 -26.63%Perf Year-4.14%
Cash/sh0.71P/FCF22.28EPS past 3/5Y-ROIC2.52%52W Low58.89 11.92%Perf 3Y-
Dividend Est.-EV/EBITDA17.33Sales past 3/5Y7.35% 10.98%Gross Margin64.37%Volatility1.91% 2.20%Perf 5Y-
Dividend TTM-EV/Sales3.55EPS Y/Y TTM132.65%Oper. Margin11.77%ATR (14)1.81Perf 10Y-
Dividend Ex-DateJul 26, 2023Quick Ratio0.78Sales Y/Y TTM8.63%Profit Margin5.57%RSI (14)54.46Recom2.63
Dividend Gr. 3/5Y0.00% 0.00%Current Ratio1.27EPS Q/Q26.04%SMA202.63%Beta0.63Target Price80.33
Payout0.00%Debt/Eq0.30Sales Q/Q7.98%SMA502.51%Rel Volume1.36Prev Close65.05
Employees16,000LT Debt/Eq0.33EarningsSep 02SMA200-9.30%Avg Volume2.80MPrice65.91
IPO DateJan 21, 1983Option/ShortYes / YesEPS/Sales Surpr.10.00% 2.66%Net Debt/EBITDA2.68Volume3,794,452Change1.32%
Analyst Ratings
DateActionAnalystRatingTarget
Jun-05-26ReiteratedNeedhamBuy$99 → $86
Jun-05-26ReiteratedWells FargoEqual Weight$480 → $66
Jun-04-26ReiteratedMizuho Securities$100 → $85
Jun-01-26ReiteratedPiper SandlerOverweight$94 → $86
May-27-26ReiteratedGoldman SachsSell$69 → $61
Feb-03-26ReiteratedNeedhamBuy$100 → $99
Jan-26-26ReiteratedBarclaysOverweight$91 → $98
Jan-09-26ReiteratedGoldman SachsSell$71 → $73
Dec-08-25ReiteratedBarclays$85 → $91
Dec-08-25ReiteratedGoldman SachsSell$64 → $71
Latest News
Jun-18-26
Jun-18-2612:35PM
These S&P500 stocks are moving in today's pre-market sessionChartMill
Jun-17-26
Jun-17-2611:00AM
3 Value Stocks We Find RiskyYahoo
Jun-16-26
Jun-16-2612:07PM
Cooper Companies Stock: Is COO Underperforming the Healthcare Sector?Yahoo
Jun-14-26
Jun-14-2607:13AM
Cooper Companies (COO) Stock After DCF Discount And High P/E RatioYahoo
Jun-12-26
Jun-12-2602:43PM
Multiple Catalysts Prompted The London Company Small-Mid Cap Strategy’s Cooper Companies (COO) AdditionYahoo
Jun-11-26
Jun-11-2605:37PM
Medical Devices & Supplies - Diversified Stocks Q1 Highlights: CooperCompanies (NASDAQ:COO)Yahoo
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
10/31/2025
FY 2024
10/31/2024
FY 2023
10/31/2023
FY 2022
10/31/2022
FY 2021
10/31/2021
FY 2020
10/31/2020
FY 2019
10/31/2019
FY 2018
10/31/2018
Total Revenue4,2314,0923,895
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A1,5071,6101,300
Gross Profit2,7232,4832,596
Selling, General and Administrative Excl. Other1,9071,6281,534
Research and Development173172155
Other Operating Expense1450201
Operating Income498683706
Interest Expense92100114
Unusual Expense
———
Non-Operating Income (Expense)17539
Net Income Before Taxes413567582
Income Taxes177192190
Consolidated Net Income236375392
Net Income From Continuing Operations236375392
Net Income236375392
EPS (Recurring)1.181.881.97
EPS (Basic, Before Extraordinaries)1.181.881.97
EPS (Diluted)1.181.871.96
EBITDA8661,0531,072
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio55.8637.39—
Price To Sales Ratio3.043.42—
Gross Margin64.3660.6866.65
Operating Margin11.7716.6918.13
Net Margin5.589.1610.06
Shares Outstanding195200199
Market Capitalization12,85213,982—
Operating Lease Expense
———
Insider Trading Volume
$70.43$61.31$52.20$43.09$33.97● Close Price0.00M0.33M0.65M0.98M1.30MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Rosebrough Walter M JrDirectorApr 01 '26Option Exercise0.001,6640832Apr 21 12:00 AM
Carbone BarbaraDirectorApr 01 '26Option Exercise0.006,10003,050Apr 06 12:00 AM
WEISS ROBERT SDirectorApr 01 '26Option Exercise0.007,3080292,599Apr 06 12:00 AM
MADDEN TERESA SDirectorApr 01 '26Option Exercise0.006,644015,679Apr 06 12:00 AM
Lucchese Cynthia LDirectorApr 01 '26Option Exercise0.006,644012,767Apr 06 12:00 AM
Kurzius Lawrence ErikDirectorApr 01 '26Option Exercise0.006,644011,099Apr 06 12:00 AM
Jay ColleenDirectorApr 01 '26Option Exercise0.006,644039,907Apr 06 12:00 AM
Rivas MariaDirectorApr 01 '26Option Exercise0.006,64403,322Apr 06 12:00 AM
Jay ColleenDirectorJan 12 '26Option Exercise39.4014,128556,64436,585Jan 14 12:00 AM
McBride Daniel GEVP & Chief Operating OfficerJan 08 '26Option Exercise0.0025,774076,007Jan 12 12:00 AM
Andrews Brian GEVP, CFO & TreasurerJan 08 '26Option Exercise0.007,056010,430Jan 12 12:00 AM
Warner Gerard H IIIPresident, CooperVision, Inc.Jan 08 '26Option Exercise0.0021,804029,837Jan 12 12:00 AM
White Albert G IIIPresident & CEOJan 08 '26Option Exercise0.0036,6800254,491Jan 12 12:00 AM
Sheffield Holly RPresident, CSIJan 08 '26Option Exercise0.0016,100047,102Jan 12 12:00 AM
Lucchese Cynthia LDirectorDec 22 '25Buy84.061,784149,9639,445Dec 23 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR